New name aligns with mission to deliver precision biomarker-based testing for both transplant and oncology careiMDx sponsoring GraftAssureIQ research-use-only kits at transplant labs globallyExhibitin ...

In addition to being faster and less invasive than a traditional tissue biopsy, the blood test is also potentially more ...

Natera, Inc. shows strong revenue growth with Medicare-backed Signatera, but faces litigation risks and valuation challenges.

Studying the chemical signatures of DNA fragments in the blood could help scientists pinpoint the cause of organ damage ...

However, the 5hmC modification status in circulating cell-free DNA (cfDNA) of patients with SLE remains largely unexplored. We investigated the distribution of 5hmC in cfDNA of patients with SLE and ...